Nasdaq IPOs

Kronos Bio, a Phase 2 biotech developing kinase inhibitor therapies for leukemia and solid tumors, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company's lead candidate, entospletinib (ENTO), is an orally administered, selective sple

Shattuck Labs, a Phase 1 biotech developing dual-sided fusion protein therapies for cancer, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company's lead candidate, SL-172154, is designed to simultaneously inhibit the CD47/SI

Social Capital Hedosophia Holdings VI, the sixth blank check company formed by Social Capital and Hedosophia targeting a tech business, filed on Friday with the SEC to raise up to $1.0 billion in an initial public offering. The Palo Alto, CA-based company plans to raise $1.0 bill

Social Capital Hedosophia Holdings V, the fifth blank check company formed by Social Capital and Hedosophia targeting a tech business, filed on Friday with the SEC to raise up to $650 million in an initial public offering. The Palo Alto, CA-based company plans to raise $650 milli

Social Capital Hedosophia Holdings IV, the fourth blank check company formed by Social Capital and Hedosophia targeting a tech business, filed on Friday with the SEC to raise up to $350 million in an initial public offering. The Palo Alto, CA-based company plans to raise $350 mil

In another busy week for the September IPO market, eight IPOs are scheduled to raise $2.0 billion, led by prescription drug marketplace GoodRx Holdings (GDRX).  The largest deal of the week, GoodRx (GDRX) plans to raise $900 million at an $11.2 billion market

Empower Ltd., a blank check company formed by MidOcean Partners, filed on Friday with the SEC to raise up to $250 million in an initial public offering. The New York, NY-based company plans to raise $250 million by offering 25 million units at $10. Each unit consists of one share

NextGen Acquisition, a blank check company targeting the industrial and healthcare sectors, filed on Friday with the SEC to raise up to $350 million in an initial public offering. The Boca Raton, FL-based company was founded in 2020 plans to list on the Nasdaq under the symbol NG

In one of the busiest weeks for initial public offerings this year, Nasdaq welcomed 14 IPOs as companies look to tap the public markets in anticipation of more volatility around the U.S. election.

Palantir Technologies, a data analytics platform focused on the government and financial sectors, is expected to begin trading on the NYSE on Tuesday, September 29, 2020, according to an amendment filed with the SEC on Friday. The company originally planned to begin trading

COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27%

COMPASS Pathways, a British Phase 2 biotech developing a psilocybin-based therapy for depression, raised $128 million by offering 7.5 million ADSs at $17, above the range of $14 to $16. The company offered 0.8 million more ADSs than anticipated. At pricing, the company raised 27%

Athira Pharma, a Phase 2/3 biotech targeting the novel HGF/MET pathway for Alzheimer's, raised $204 million by offering 12 million shares at $17, the high end of the range of $15 to $17. The company offered 2 million more shares than anticipated. At pricing, the company raised 28

BioVie, a Phase 2 biotech developing therapies for cirrhosis, raised $16 million by offering 1.6 million shares at $10, below the last close of its shares on the OTC (BIVI). The company offered 0.3 million more shares than anticipated. BioVie plans to list on the Nasdaq under the

Vitru, which provides online and tutored post-secondary education services in Brazil, raised $96 million by offering 6 million shares (100% primary) at $16, the low end of the downwardly revised range of $16 to $18. The company originally planned to offer 11.2 million shares (53%

Alpha Healthcare Acquisition, a blank check company targeting a healthcare business in the US, raised $100 million by offering 10 million units at $10. Each unit consists of one share of common stock and one-half of a warrant, exercisable at $11.50. The company is led by&nbs

Unity Software, which provides a real-time 3D video game development platform, raised $1.3 billion by offering 25 million shares at $52, above the upwardly revised $44 to $48 range.  The San Francisco, CA-based company originally planned to offer shares at $34 to $42, before

Wunong Net Technology, which operates an online food retail store and franchise restaurants in China, filed on Thursday with the SEC to raise up to $25 million in an initial public offering. The Shenzhen, China-based company plans to raise $25 million by offering 5 million shares

ACON S2 Acquisition, a blank check company formed by ACON Investments targeting a sustainable business, raised $250 million by offering 25 million units at $10. Each unit consists of one share of common stock and one-third of a warrant, exercisable at $11.50. The company is

Processa Pharmaceuticals, which is developing an analog therapy for necrotic skin disease, lowered the proposed deal size for its upcoming IPO on Thursday. In its latest filing  The Hanover, MD-based company now plans to raise $18 million by offering 2.2 million shares at $8